Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|October 1, 2003
- Volume 0 0
October 2003: Rx Image One
Advertisement
Registered pharmacist Carol Collins of Winn-Dixie Pharmacy in Panama City Beach, Fla, had her work cut out for her when this prescription came into the pharmacy. Not only was the name of the drug illegible, but so was the dosage. She placed a call to the physician who prescribed the medication for clarification. Do you have any idea what drug is being ordered?
Click Here For The Answer ----------->
[
Prandin #90, 0.5 mg, po ac
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
almost 23 years ago
I recently received a prescription...almost 23 years ago
Brochure Gives Tips for Managing Painalmost 23 years ago
Seniors More Proactive About Doctor Visitsalmost 23 years ago
Is Copper a Culprit in Alzheimer's Disease?almost 23 years ago
Eye Gel Treatment Aimed to Improve Older Eyesightalmost 23 years ago
Anemia Affects Physical Tasksalmost 23 years ago
Diabetes Cases Up, Death Rate Downalmost 23 years ago
Women Prone to Earlier, Greater Bone Lossalmost 23 years ago
Test Detects Heart Disease Earlyalmost 23 years ago
Insulin Surpasses Oral DrugAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
4
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
5